Future of Health Care in Canada: OBIO Investment Summit Connects Global Investors, Leading-Edge Health Companies
Last week, 43 of the most promising companies in the Canadian health science industry came together at the OBIO Niagara Investment Summit, where they showcased their innovations to over 40 investors from across North America and Japan to pave the path to the investments needed to fully commercialize products.
OBIO 2019 Annual Public Meeting: Recap and Photo Gallery
The OBIO Annual Public Meeting took place on November 25 and included a celebration of 10 years of the organization’s contributions to Ontario’s health science sector and a look to the future with a presentation highlighting the emerging field of digital therapeutics.
OBIO in Kitchener-Waterloo Health Science Networking Event
OBIO visited Kitchener-Waterloo on November 13 to meet and network with health science companies and industry stakeholders. The day was capped off with OBIO’s Health Science Network Event, supported by Bereskin & Parr and Communitech.
OBIO Hosts: Amplify Capital
On November 4th, OBIO hosted Amplify Capital (formerly MaRS Catalyst Fund) and heard from Kathryn Worstman (Managing Partner, Amplify Capital) and Gonen Hollander (Senior Associate, Amplify Capital) present their impact investment strategy.
OBIO’s “Project Management Essentials for Every Health Science Entrepreneur” Event in Review
On October 24th, OBIO hosted “Project Management Essentials for Every Health Science Entrepreneur” led by Ashwini Bhaskar who shared from his 20 years of experience. The purpose of the workshop was to introduce basic project knowledge and common terminology, to provide insights into where to go for more information and provide some simple take-aways that could be used immediately.
Reviewing OBIO's Primary Market Research Workshop
Last week OBIO hosted Gary Svoboda (CEO, Adventus Research + Consulting) who provided the audience practical steps they can use to validate technology with primary market research.
OBIO at MedTech Conference in Boston
This year's AdvaMed MedTech Conference in Boston was a fantastic event. OBIO was in attendance for meetings and conversations with US and global investors and strategics about what's coming up for the health science industry in Canada. There was tons of enthusiasm and interest to capitalize on as we head into 2020.
Recap: OBIO CAAP Alumni Group Dinner
On September 17th, OBIO held a dinner to bring together CAAP and CAAP Alumni companies. OBIO would like to thank everyone who came out and joined us to discuss common experiences, challenges and what's coming next.
Reviewing OBIO at RESI Boston
On September 10th, OBIO organized a cross-border networking event in Boston at the Consulate General of Canada. The event was supported by the Consulate General and law firms Fasken and Choate. Over 45 investors, strategics, as well as executives from high potential Canadian health science companies packed the Canada Room at the Consulate and resulted in numerous investor-company interactions.
FedDev Ontario announces $6.24 million investment in OBIO
FedDev Ontario is investing up to $6.24 million for the Ontario Bioscience Innovation Organization (OBIO®) to boost investment, market access and mentorship opportunities for companies across southern Ontario looking to commercialize their medical innovations.
Reviewing 'In-Licensing from Tech Transfer Offices: Terms, Tips & Impact on Investability'
On August 21st, OBIO hosted Norton Rose Fulbright’s Anthony de Fazekas (Partner, Head of Technology & Innovation) and Vanessa Grant (Partner), Lumira Ventures’ Jacki Jenuth (Partner), and University of Toronto’s Karen Temple (Commercialization Manager) who discussed practical considerations for licensing health science technologies from tech transfer offices, and how these agreements can impact a company’s future investability.
OBIO Hosts Happy Hour Networking Event
On July 25th, OBIO hosted a Happy Hour Networking event attended by over 40 CEOs and senior health science company executives. Attendees networked with fellow entrepreneurs and heard about OBIO’s upcoming plans for the fall.
OBIO Announces National Call to Canadian Health Science Companies for Applications for the 2020 Niagara Investment Summit
The OBIO 2020 Niagara Investment Summit national call for applications from health science companies that are seeking Series A or beyond investments is now open.
Recapping 'Optimize Your Next Round of Funding'
On July 11th, OBIO presented the “Optimize your next round of funding” workshop for CAAP & Health MINT companies. The workshop was led by Nick Kuryluk of Virtus Insights.
Reviewing 'Is the Price Right? Pricing Your Innovative Healthcare Product'
On June 25th, OBIO hosted 'Is the Price Right? Pricing Your Innovative Healthcare Product' which featured a presentation by Amy Siegel (C-Founder, S2N Health).
Send OBIO Your Red Tape Reduction Ideas
If your company has experience with an unnecessary, duplicative or frustrating hurdle in the course of doing business, OBIO wants to know. Please tell us what the challenges are and how they impact your company. As part of OBIO’s engagement with the provincial government, the health science industry’s recommendations on red tape or regulatory burdens that can be addressed are being sought by the Government of Ontario.
Recapping Pitches & Pitchers
On June 10th, OBIO hosted a Pitches & Pitchers event, supported by Lumira Ventures and Whitecap Venture Partners.
Why Ontario needs a network of Early Adopter Health Organizations: Biotechnology Focus
In the latest issue of Biotechnology Focus, OBIO President and CEO Gail Garland contributed a special report: Why Ontario needs a network of Early Adopter Health Organizations
Recapping 2019 OBIO Queen's Park Health Science Industry Showcase
On May 13th, OBIO hosted the 2019 Queen’s Park Health Science Industry Showcase which attracted over 100 attendees, including Ministers, MPPs, government officials and health science industry leaders who came to see the latest in health care innovation from our displaying companies.
Apply to Pitch and Get Feedback from the Mid Atlantic Bio Angels, May 23
Apply to be one of 4 OBIO member companies to pitch to the Mid Atlantic Bio Angels (MABA), a group of active angel investors based in New York City. Companies will receive constructive feedback on what they need to have in place prior to applying for investment from MABA or similar groups to improve their chances of getting investment.